Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
orantinib (TSU-68)
i
Other names:
TSU-68, SU 6668, SU006668, TSU 68
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Otsuka, Pfizer
Drug class:
c-KIT inhibitor, FGFR inhibitor, PDGFR inhibitor, VEGFR-2 inhibitor
Related drugs:
‹
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
BAY 57- 9352 (0)
PTK787 (0)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
SYHA1817 (0)
Max-40279 (2)
vorolanib (1)
squalamine (0)
pegpleranib (0)
R1530 (0)
ABT348 (0)
rivoceranib (82)
ramucirumab (59)
RAF265 (7)
tivozanib (3)
GSK1363089 (2)
KC1036 (1)
BMS-582664 (1)
pegdinetanib (0)
BMS690514 (0)
BTG-002814 (0)
C019199 (0)
JI-101 (0)
JY025 (0)
MG-D-1509 (0)
MSB0254 (0)
NCE 401 (0)
VEGFR2-169 (0)
VXM01 (0)
DCC-2701 (0)
Gensci048 (0)
gentuximab (0)
TTAC-0001 (0)
AK109 (0)
ASA404 (0)
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
BAY 57- 9352 (0)
PTK787 (0)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
SYHA1817 (0)
Max-40279 (2)
vorolanib (1)
squalamine (0)
pegpleranib (0)
R1530 (0)
ABT348 (0)
rivoceranib (82)
ramucirumab (59)
RAF265 (7)
tivozanib (3)
GSK1363089 (2)
KC1036 (1)
BMS-582664 (1)
pegdinetanib (0)
BMS690514 (0)
BTG-002814 (0)
C019199 (0)
JI-101 (0)
JY025 (0)
MG-D-1509 (0)
MSB0254 (0)
NCE 401 (0)
VEGFR2-169 (0)
VXM01 (0)
DCC-2701 (0)
Gensci048 (0)
gentuximab (0)
TTAC-0001 (0)
AK109 (0)
ASA404 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login